ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ENZ Enzo Biochem Inc

1.13
0.00 (0.00%)
Apr 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price
Ask Price
News -
Day High

Low
1.07

52 Week Range

High
2.74

Day Low
Company Name Stock Ticker Symbol Market Type
Enzo Biochem Inc ENZ NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 1.13 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.13
Trades Volume Avg Volume 52 Week Range
0 0 - 1.07 - 2.74
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 1.13 USD

Enzo Biochem Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
56.86M 51.23M - 31.06M 20.29M 0.40 2.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Enzo Biochem News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ENZ Message Board. Create One! See More Posts on ENZ Message Board See More Message Board Posts

Historical ENZ Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.241.241.071.16110,453-0.11-8.87%
1 Month1.221.301.071.2191,915-0.09-7.38%
3 Months1.291.401.071.29103,696-0.16-12.40%
6 Months1.391.501.071.31106,406-0.26-18.71%
1 Year2.552.741.071.58170,957-1.42-55.69%
3 Years3.294.151.002.42231,256-2.16-65.65%
5 Years3.565.501.002.84364,211-2.43-68.26%

Enzo Biochem Description

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

Your Recent History

Delayed Upgrade Clock